FDA's Pazdur Won't Become Oncology Bureaucrat: 'My Presence Will Be Felt'

Richard Pazdur is stepping aside from FDA's Office of Hematology and Oncology Products to head the agency's newly created Oncology Center of Excellence, but he expects to still run twice-weekly group meetings at OHOP.